Claudio Rumazza is a Venture Capital investor, Partner at Innogest. He focuses on healthcare investments and in particular on medical devices, diagnostics and digital health.
Claudio currently serves on the Board or is involved as a Board observer in Erydel SpA, Igea SpA, D-Eye Srl, Atricath Srl Beintoo SpA, Angiodroid Srl, Pi-Cardia Ltd. and Newronika Srl.
Before joining Innogest, Claudio was the CFO of Finn-Power Group, head of Financial Planning and Control at Prima Industrie Group and before that he was a consultant with Deloitte Financial Advisory.
Claudio has a bachelor degree in business administration from University of Torino.
